---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-22-005111"
form_type: "8-K"
ticker: "SVRA"
cik: "0001160308"
company_name: "Savara Inc"
filed_at: "2022-01-10T23:59:59+00:00"
generated_at: "2026-06-27T19:12:51.275874+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "low"
source: SEC EDGAR
---

# Savara updates corporate presentation; no specific financial or clinical data disclosed in filing

## Summary
- Corporate presentation furnished as Exhibit 99.1, available on Savara's IR website.
- Presentation title indicates continued focus on rare respiratory diseases.
- No material changes or new quantitative information provided in the 8-K or exhibit.

## SEC filing metadata
- accession: 0001193125-22-005111
- form_type: 8-K
- ticker: SVRA
- cik: 0001160308
- company_name: Savara Inc
- filed_at: 2022-01-10T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1160308/000119312522005111/0001193125-22-005111-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1160308/000119312522005111/d264857d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-22-005111
- JSON: https://secwatch.observer/filing/0001193125-22-005111.json
- Plain text: https://secwatch.observer/filing/0001193125-22-005111.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.